In reversal, U.S. agrees to review new Moderna flu shot

2026-02-18 - 22:03

Vaccine manufacturer Moderna said Wednesday the U.S. Food and Drug Administration walked back its previous position and agreed to review the company's new mRNA-based flu shot. Last week...